Dr. Reddy's launches novel drug for chronic constipation management
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The company has improved access to quality healthcare for seniors across both urban and rural areas
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Subscribe To Our Newsletter & Stay Updated